Login / Signup

Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.

Haiyang TangAkash GuptaSeth A MorrisroeChanglei BaoTae-Hwi Schwantes-AnGeetanjali GuptaShuxin LiangYanan SunAiai ChuAng LuoVenkateswaran Ramamoorthi ElangovanShreya SangamYinan ShiSamisubbu R NaiduJia-Rong JhengSultan Ciftci-YilmazNoel A WarfelLouise HeckerSumegha MitraAnna W ColemanKatie A LutzMichael W PauciuloYen-Chun LaiAli JavaheriRohan DharmakumarWen-Hui WuDaniel P FlahertyJason H KarnesSandra Breuils-BonnetOlivier BoucheratSebastien BonnetJason X-J YuanJeffrey R JacobsonJulio D DuarteWilliam C NicholsJoe G N GarciaAnkit A Desai
Published in: Circulation (2024)
Our findings suggest that UCHL1 deficiency results in PAH attenuation by means of reduced AKT1, highlighting a novel therapeutic pathway in PAH.
Keyphrases
  • pulmonary arterial hypertension
  • pulmonary artery
  • pulmonary hypertension
  • polycyclic aromatic hydrocarbons
  • replacement therapy
  • signaling pathway
  • cell proliferation
  • coronary artery